Siga Technologies (SIGA) Restructuring Costs (2013 - 2016)

Siga Technologies' (SIGA) quarterly Restructuring Costs came in at $2.9 million in Q1 2016, down 79.7% on a QoQ basis from $14.4 million in Q4 2015.

Siga Technologies (SIGA) Restructuring Costs (2013 - 2016) Analysis & Trends

Siga Technologies (SIGA) has 4 years of Restructuring Costs data on file, last reported at $2.9 million in Q1 2016.

Quarterly Restructuring Costs changed N/A year-over-year to $2.9 million in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $17.3 million (down 90.82% YoY) and the FY2015 annual result came in at $14.4 million, down 92.36% from the prior year.
Restructuring Costs declined to $2.9 million in Q1 2016, from $14.4 million in the prior quarter.
In the past five years, Restructuring Costs ranged from a high of $175.5 million in Q3 2014 to a low of $14000.0 in Q3 2015.
A 4-year average of $18.8 million and a median of $51000.0 in 2013 frame the typical range for Restructuring Costs.
Annual changes were most pronounced in 2014 — Restructuring Costs jumped 343950.98% — and 2015, when it tumbled 99.99%.
Tracing SIGA's Restructuring Costs over 4 years: stood at $366276.0 in 2013, then soared by 3421.66% to $12.9 million in 2014, then gained by 11.38% to $14.4 million in 2015, then tumbled by 79.7% to $2.9 million in 2016.
The last three Restructuring Costs figures came in at $2.9 million (Q1 2016), $14.4 million (Q4 2015), and $14000.0 (Q3 2015), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-
10	Siga Technologies	214.10 Mn	59.13 Mn	-

Download Data